By a GenomeWeb staff reporter
 
NEW YORK (GenomeWeb News) – French cell-based assays developer Cytoo said this week that it has raised $10 million in a Series C financing round.

The round included new investors Sham, which is a French mutual insurance company, and venture capital firm Entrepreneurs Fund. Previous investors including Auriga Partners and Cytoo Co-founder and Supervisory Board President Jacques Lewiner also participated in the financing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.